(R)-tert-butyl 3-methyl-5-oxopiperidine-1-carboxylate, 95%, 250mg

(S)-Methyl 2-hydroxy-3-phenylpropanoate, 95.0%, 25g

tert-Butyl 2-((4R,6S)-6-((E)-2-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate, 97%, 100g

Tert-butyln-[(5-bromothiazol-2-yl)methyl]carbamate, 98%, 5g

(5E)-5-(5-chloro-2-ethoxybenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one, 95.0%, 1g

1,1-Diethyl-3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 98%, 250mg

1-Methylimidazole-4-sulfonamide, 1g

tert-Butyl 3-(2-oxoindolin-3-yl)piperidine-1-carboxylate, 97%, 5g

5-Nitro-naphthalene-1-carboxylic acid, 95+%, 25g

3-(piperidin-4-yl)-3H,4H-pyrido[2,3-d]pyrimidin-4-one dihydrochloride, 95.0%, 250mg

3-Bromo-4,5-difluoronitrobenzene, 97.0%, 5g

D-Azidolysine hydrochloride, min. 98%, 100 mg, plastic packaging.

4'-(4-Methoxycarbonylphenyl)-2,2':6',2''-terpyridine, 97%, 100mg